Ovarian Cancer Market Research Reports

Your Ovarian Cancer Market Guide with research reports, industry analysis, market forecasts, market share, size, etc.
RSS Sort By :
TITLE Price Buy Now More options

DelveInsight’s, “Ovarian Cancer - Treatment Landscape & Competitive Analysis, 2017”, report provides comprehensive insights about the treatment landscape across this indication. This report also provides the deep understanding of the stages of the ov...

$ 2450


This study focuses on China’s Ovarian Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consum...

$ 1800


China's demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the co...

$ 4000


This study focuses on China’s Ovarian Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in Chin...

$ 1800


This report studies Ovarian Cancer Drugs in Global market, especially in North America, Europe, China, Japan, Latin America and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each ...

$ 2955


Notes: Production, means the output of Ovarian Cancer Drugs Revenue, means the sales value of Ovarian Cancer Drugs This report studies Ovarian Cancer Drugs in Global market, especially in North America, Europe, China, Jap...

$ 2900


DelveInsight’s Report, “Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacros...

$ 2000


DelveInsight’s Report, “Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe...

$ 2000


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.Ovarian cancer is any cancerous growth that may...

$ 2500


Ovarian cancer (International Classification of Diseases, 10th Revision [ICD-10] code C56) and cancer of the fallopian tubes and other uterine adnexa (ICD-10 C57) are leading causes of cancer mortality in women (ACS, 2016; CDC, 2016). Cancer of th...

$ 3995


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epithelial Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Epithelial Ovarian Cancer (Oncology) pipeline landscape.Ovarian epithelial cancer...

$ 2000


The global women’s health diagnostics market is projected to reach USD 36.64 billion by 2021, growing at a CAGR of around 7.9% during the forecast period. Growth in this market can be attributed to a number of factors such as high prevalence...

$ 5650


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic Ovarian Cancer (Oncology) pipeline landscape.Metastatic ovarian cancer...

$ 2000


Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData''s Medical Devices sector report, “Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overvi...

$ 4000


Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016 Summary GlobalData''s clinical trial report, “Metastatic Ovarian Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Metastatic Ovarian Can...

$ 2500


Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Ovarian Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ovarian Cancer,...

$ 2500


Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Epithelial Ovarian Cancer pipeline landscape.The report provides comprehensive information on the therapeuti...

$ 2000


GlobalData's clinical trial report, "Ovarian Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Ovarian Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Ovari...

$ 2500


Global Markets Direct’s, ‘Metastatic Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Ovarian Cancer pipeline landscape.The report provides comprehensive information on the therapeuti...

$ 2000


Ovarian Cancer - Heat Map and Analysis Summary Ovarian Cancer (OC) is the fifth most common malignancy diagnosed in women, and the most common gynecological cancer, with an estimated 225,000 new cases diagnosed globally ...

$ 2000

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: